Who ever wondered that a common BP drug may help slow down the dreaded diabetic eye damages ?
Scientists have found that a drug, commonly prescribed to treat high blood pressure, could slow the progression of eye damage in people with type 1 diabetes, a common complication caused by this disease.
By administering an antihypertensive, University of Minnesota Medical School researcher Michael Mauer, M.D. and colleagues were able to slow progression of diabetic eye damage in more than 65 percent of participants involved in the study.
Three groups of participants were observed over the course of five years. Two groups were administered one of two antihypertensive medications, losartan or enalapril, and the last group, a placebo.
Mauer’s study demonstrated that participants who were administered either enalapril or losartan experienced a significant slowing of the progression of diabetic eye injury, by 65 and 70 percent, respectively.
“The secondary results of this study showed that people taking these antihypertensive medications experienced a substantially positive effect in slowing diabetic eye injury,” said Mauer.
The study has been published in the July 2nd issue of The New England Journal of Medicine.
Source: ANI
Filed under Eye Treatment | Tags: antihypertensive, blood pressure drug, diabetic eye damages, eye, type 1 diabetes, University of Minnesota Medical School | 1 Comment
Related?
Glaucoma now terrorising GhananiansAugust 20th, 2008 Recent research done by an Ophthalmologist, Dr. Winfried Amoaku and his associates involving the residents of Akwapim South district of Eastern Region, reveals that Ghanaians of age 30 and above are more prone to suffer from Glaucoma.
Glaucoma May Become A Major Threat To Asian CountriesJuly 6th, 2008 In a survey it is found that by 2010 more than 8.4 million people in Asia will turn blind from Glaucoma, if not treated properly in time. Glaucoma is a disease which is the second leading cause of blindness after Cataract.
South Asians are prone to higher risk of diabetic retinopathyApril 3rd, 2009 Researcher at University of Warwick, Coventry, U.K.,claimed that South Asians diabetics who are suffering from type 2 diabetes are having a higher tendendy to get diabetic eye disease, which is also known as diabetic reinopathy, much earlier than White Europeans type 2 diabetics
The study reveled that diabetic retinopathy that damage the tiny blood vessels supplying blood to the retina is more prevalent in South Asians than White European diabetics. It also occurs early in Asian diabetics than white Europeans.
Contact lenses May Control Blood Sugar LevelFebruary 24th, 2006 Diabetics could soon be wearing contact lenses that warn them when their blood sugar level is dangerously high or low. Scientists are developing the devices that use 'sensor hologram' technology that senses the glucose levels so sufferers will no longer have to take blood samples daily.
Blood pressure drug Candesartan retain hope for diabetic ratinopathyJanuary 7th, 2009 New clinical trials bring hope for diabetes patents facing diabetic retinopathy, a disease which has the potential of causing blindness. Diabetic retinopathy is a hidden danger for diabetic patients, Small blood vessels throughout the entire body are destroyed due to type 1 diabetes.
Corneal arcus is prevalent among diabeticsJuly 15th, 2009 An eye condition picked up in annual eye exams can aid early identification of a variety of other health conditions, according to a new study released by VSP
Ninety-eight percent of study participants who had a grayish-white ring around the cornea — a condition called corneal arcus — also had metabolic problems related to conditions such as diabetes, high blood pressure and high cholesterol, concludes a study conducted by VSP and the Columbus Research Foundation in Columbus, Ga. Until now, health professionals have assumed arcus is related to high cholesterol.
Diabetic retinopathy links obstructive sleep apneaMay 20th, 2009 Eye, which was known as the window of soul have extended its capability and approved by the medical world also as the window of medical information. New study confirms that diabetics with retinopathy is having a higher chance to suffer from obstructive sleep apnea (OSA).
Lumigan, Allergan's Intraocular Pressure Drug, Received FDA ApprovalJune 29th, 2006 The FDA has approved Allergan's once-daily prescription eye drop Lumigan as a first-line treatment for elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension. The Lumigan first-line indication is in addition to the product's already established use as a second-line treatment, for which the FDA approved the drug in 2001.
